Abivax (ABVX) Stock Insights

ABVX price $89.84 +2.84 +3.26%

Ticker
ABVX
Price
$89.84
Change
+2.84 +3.26%
Market cap ?
$7.72B
P/E ?
-16.62
Forward P/E ?
29.68
Dividend yield ?
0.00%
Beta ?
-0.25
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
76
Value
55
Quality
74
Growth
99

Stocklytics score rationale: value 55, quality 74, growth 99.

Financials

2016201720182019202020212022202320242025
127000100001800020006300000000

Abivax S.A., operating as ABIVAX Société Anonyme, is a French pharmaceutical firm focused on the discovery and optimization of therapeutic drugs for inflammatory, infectious, and oncological diseases. A cornerstone of their product pipeline is ABX464, which is currently undergoing Phase IIb clinical trials for ulcerative colitis, Crohn's Disease, and COVID-19. This compound is also being evaluated in Phase IIa…

Fair value

ABVX fair value $41.61. Price $89.84. Price is 116% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 21.83K. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.00%. Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 85.94M. Net debt -470.58M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare ABVX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-12-21—-0.92—922.55K
2026-09-21-1.71-0.981.37M799.17K
2026-05-22-0.71-1.071.51M401.12K
2026-03-23-1.19-1.70515.06K1.80M
2025-12-15-2.47-0.792.40M1.35M
2025-09-08-0.86-0.901.33M1.39M
2025-06-02-0.97-0.761.16M3.35M
2025-03-24-1.68-1.596.37M2.83M
2024-11-14-0.70-0.70—3.59M
2024-09-09-1.44-0.747.16M3.78M
2024-04-02-1.94-0.912.50M2.47M
2023-09-21-1.55-0.672.46M1.22M
2023-04-19—-1.93—1.26M
2022-12-31-1.95-1.932.42M—
2022-09-15-1.84—2.33M—
2022-03-16-1.68———
2021-09-23-1.34———
2021-03-31-1.90———
2020-09-24-1.42———
2020-03-16-1.53———
2019-06-30-1.57———
2018-12-31-0.98—385.95K—
2018-06-30-0.84—571.13K—
2017-12-31-0.66—413.00K—
2017-06-30-0.65—4.56K—
2016-12-31-0.64—14.69K—
2016-06-30-0.95—152.27K—
2015-12-31-0.97—-89.48K—
2015-06-30-0.83—343.73K—
2014-12-31-0.62—245.33K—
2014-06-30-0.10———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
No data yet.

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 368, holders +82 vs prior quarter. Ownership 79.06%.

HolderSharesChangeChange %Value
TCG CROSSOVER MANAGEMENT, LLC6.01M-473.25K-7.30%800.60M
HELIKON INVESTMENTS LTD2.79M1.77M+175.05%371.41M
DARWIN GLOBAL MANAGEMENT, LTD.3.62M152.93K+4.41%348.22M
SUSQUEHANNA INTERNATIONAL GROUP, LLP2.46M2.08M+551.17%327.66M
VESTAL POINT CAPITAL, LP2.35M849.44K+56.63%313.09M
JUPITER TOPCO LLC1.91M1.91MNew255.13M
UBS GROUP AG1.84M-2.70M-59.43%245.85M
ADAR1 CAPITAL MANAGEMENT, LLC1.80M410.68K+29.46%240.49M
CITADEL ADVISORS LLC1.60M1.28M+391.82%213.86M
CALIGAN PARTNERS LP1.56M96.00K+6.57%207.61M
CITADEL ADVISORS LLC1.44M1.11M+340.81%191.67M
MORGAN STANLEY1.43M-272.77K-16.00%190.85M
WESTFIELD CAPITAL MANAGEMENT CO LP1.31M-13.11K-0.99%174.55M
CITADEL ADVISORS LLC1.20M874.30K+267.94%159.99M
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.14M757.60K+200.64%151.28M
RA CAPITAL MANAGEMENT, L.P.1.13M1.13MNew150.92M
NORGES BANK1.10M1.10MNew146.59M
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.05M676.30K+179.10%140.44M
LOGOS GLOBAL MANAGEMENT LP1.02M349.00K+51.70%136.46M
OCTAGON CAPITAL ADVISORS LP993.00K316.00K+46.68%132.33M
BANK OF AMERICA CORP /DE/971.44K235.71K+32.04%129.45M
EVERSEPT PARTNERS, LP913.88K-20.54K-2.20%121.78M
GOLDMAN SACHS GROUP INC792.71K443.92K+127.27%105.64M
NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A.765.33K-583-0.08%101.99M
CORMORANT ASSET MANAGEMENT, LP675.00K-85.00K-11.18%89.95M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Abivax (ABVX) Stock Insights

ABVX$89.84+2.84 +3.26%

$7.72B

Market Cap

-16.62

P/E

29.68

Forward P/E

76

Score

Price History